Form 4: Know Labs Director Acquires 1,000,000 Options in Latest Transaction
SEC Form 4 Filing
Director John E. Cronin reports acquisition of 1,000,000 options to purchase Know Labs, Inc. common stock.
Summary
- On September 11, 2024, John E. Cronin, a director of Know Labs, Inc., acquired 1,000,000 options to purchase common stock.
- The options have an exercise price of $0.299 and expire on September 11, 2029.
- The options become exercisable ratably over a four-year period from the date of grant.
- Following the transaction, Cronin directly owns 16,164 shares of common stock and options to purchase 1,490,411 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider activity. The acquisition of options could be seen as a positive signal, but it's not definitive.
Positives
- A director's acquisition of a significant number of options could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The market often interprets insider activity as a signal of management's view on the company's prospects.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive sign.
Key Dates
| Date | Description |
|---|---|
| 10/10/2023 | Date of exercisable options to purchase common stock |
| 11/10/2023 | Date of exercisable options to purchase common stock |
| 02/08/2024 | Date of exercisable options to purchase common stock |
| 09/11/2024 | Date of transaction: Director acquired 1,000,000 options to purchase common stock |
| 09/24/2024 | Date of signature |
| 02/08/2029 | Expiration date of options to purchase common stock |
| 09/11/2029 | Expiration date of options to purchase common stock |
| 10/10/2028 | Expiration date of options to purchase common stock |
| 11/10/2028 | Expiration date of options to purchase common stock |
Keywords
Know Labs, Director, Options, Common Stock, Acquisition, Cronin, KNW
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.